Á lódáil...
Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins
CRISPR-Cas systems are bacterial adaptive immune pathways that have revolutionized biotechnology and biomedical applications. Despite the potential for human therapeutic development, there are many hurdles that must be overcome before its use in clinical settings. Some clinical safety concerns arise...
Na minha lista:
| Foilsithe in: | RNA |
|---|---|
| Main Authors: | , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Cold Spring Harbor Laboratory Press
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6795140/ https://ncbi.nlm.nih.gov/pubmed/31439808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1261/rna.071704.119 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|